{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T01:18:09Z","timestamp":1770340689737,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Health Research Project of Kunming Health Commission","award":["2022 04 05 005"],"award-info":[{"award-number":["2022 04 05 005"]}]},{"name":"Health Research Project of Kunming Health Commission","award":["2022 04 05 005"],"award-info":[{"award-number":["2022 04 05 005"]}]},{"name":"Health Research Project of Kunming Health Commission","award":["2022 04 05 005"],"award-info":[{"award-number":["2022 04 05 005"]}]},{"name":"Yunnan Fundamental Research Projects","award":["KUST-AN2023005Q"],"award-info":[{"award-number":["KUST-AN2023005Q"]}]},{"name":"Yunnan Fundamental Research Projects","award":["KUST-AN2023005Q"],"award-info":[{"award-number":["KUST-AN2023005Q"]}]},{"name":"Yunnan Fundamental Research Projects","award":["KUST-AN2023005Q"],"award-info":[{"award-number":["KUST-AN2023005Q"]}]},{"name":"Yunnan Fundamental Research Projects","award":["KUST-AN2023005Q"],"award-info":[{"award-number":["KUST-AN2023005Q"]}]},{"name":"Yunnan Fundamental Research Projects","award":["KUST-AN2023005Q"],"award-info":[{"award-number":["KUST-AN2023005Q"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05663-9","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:34:29Z","timestamp":1747110869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A comparative study of mirabegron versus doxazosin in improving ureteral stent-related dysfunction"],"prefix":"10.1007","volume":"43","author":[{"given":"Bo","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangxiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"3","key":"5663_CR1","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/01.ju.0000048980.33855.90","volume":"169","author":"HB Joshi","year":"2003","unstructured":"Joshi HB, Stainthorpe A, MacDonagh RP et al (2003) Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol. 169(3):1065\u20139. https:\/\/doi.org\/10.1097\/01.ju.0000048980.33855.90","journal-title":"J Urol."},{"issue":"1","key":"5663_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00345-018-2376-6","volume":"37","author":"A Bosio","year":"2019","unstructured":"Bosio A, Alessandria E, Dalmasso E et al (2019) How bothersome double-J ureteral stents are after semirigid and flexible ureteroscopy: a prospective single-institution observational study. World J Urol. 37(1):201\u20137. https:\/\/doi.org\/10.1007\/s00345-018-2376-6","journal-title":"World J Urol."},{"issue":"4","key":"5663_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ajur.2018.07.002","volume":"5","author":"M Beysens","year":"2018","unstructured":"Beysens M, Tailly TO (2018) Ureteral stents in urolithiasis. Asian J Urol. 5(4):274\u201386. https:\/\/doi.org\/10.1016\/j.ajur.2018.07.002","journal-title":"Asian J Urol."},{"issue":"4","key":"5663_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1177\/03915603211048153","volume":"89","author":"A Chandna","year":"2022","unstructured":"Chandna A, Kumar S, Parmar KM et al (2022) Comparison of stent related symptoms in patients taking mirabegron, solifenacin, or tamsulosin: a double blinded randomized clinical trial. Urologia. 89(4):589\u2013596. https:\/\/doi.org\/10.1177\/03915603211048153","journal-title":"Urologia."},{"key":"5663_CR5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11075","author":"Z Kazmi","year":"2020","unstructured":"Kazmi Z, Umer D, Ather MH (2020) The effect of ureteric stenting on female sexual function: a prospective cohort study. Cureus. https:\/\/doi.org\/10.7759\/cureus.11075","journal-title":"Cureus"},{"issue":"10","key":"5663_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14564","volume":"75","author":"\u0130 \u00d6zl\u00fc","year":"2021","unstructured":"\u00d6zl\u00fc \u0130, Karaman \u00d6zl\u00fc Z, Kilin\u00e7 T et al (2021) Sexual dysfunction in patients after double-J catheterisation: a cross-sectional, prospective study. Int J Clin Pract. 75(10):e14564. https:\/\/doi.org\/10.1111\/ijcp.14564","journal-title":"Int J Clin Pract."},{"issue":"9","key":"5663_CR7","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00345-019-03012-1","volume":"38","author":"V De Coninck","year":"2019","unstructured":"De Coninck V, Keller EX, Somani B et al (2019) Complications of ureteroscopy: a complete overview. World J Urol. 38(9):2147\u20132166. https:\/\/doi.org\/10.1007\/s00345-019-03012-1","journal-title":"World J Urol."},{"issue":"4","key":"5663_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2147\/ciia.2006.1.4.389","volume":"1","author":"TJ Wilt","year":"2006","unstructured":"Wilt TJ, MacDonald R (2006) Doxazosin in the treatment of benign prostatic hypertrophy: an update. Clin Interv Aging. 1(4):389\u2013401. https:\/\/doi.org\/10.2147\/ciia.2006.1.4.389","journal-title":"Clin Interv Aging."},{"issue":"Suppl 1","key":"5663_CR9","first-page":"S1","volume":"11","author":"CG Roehrborn","year":"2009","unstructured":"Roehrborn CG (2009) Efficacy of \u03b1-adrenergic receptor blockers in the treatment of male lower urinary tract symptoms. Rev Urol 11(Suppl 1):S1","journal-title":"Rev Urol"},{"issue":"4","key":"5663_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1590\/s1677-5538.ibju.2015.0570","volume":"42","author":"L Zhang","year":"2016","unstructured":"Zhang L, Li J, Pan M et al (2016) Doxazosin oral intake therapy to relieve stent - related urinary symptoms and pain: a prospective, randomized, controlled study. Int Braz j Urol. 42(4):727\u201333. https:\/\/doi.org\/10.1590\/s1677-5538.ibju.2015.0570","journal-title":"Int Braz j Urol."},{"key":"5663_CR11","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2147\/ijwh.s372597","volume":"14","author":"M O\u2019Kane","year":"2022","unstructured":"O\u2019Kane M, Robinson D, Cardozo L et al (2022) Mirabegron in the management of overactive bladder syndrome. IJWH. 14:1337\u20131350. https:\/\/doi.org\/10.2147\/ijwh.s372597","journal-title":"IJWH."},{"issue":"4","key":"5663_CR12","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.euf.2021.10.002","volume":"8","author":"J Van Besien","year":"2021","unstructured":"Van Besien J, Keller EX, Somani B et al (2021) Mirabegron for the treatment of ureteral stent-related symptoms: a systematic review and meta-analysis. Eur Urol Focus. 8(4):1031\u20131041. https:\/\/doi.org\/10.1016\/j.euf.2021.10.002","journal-title":"Eur Urol Focus."},{"key":"5663_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00345-016-1875-6","volume":"35","author":"D Abt","year":"2017","unstructured":"Abt D, D\u00f6tzer K, Honek P, M\u00fcller K, Engeler DS, Burger M et al (2017) The German linguistic validation of the ureteral stent symptoms questionnaire (USSQ). World J Urol. 35:443\u2013447. https:\/\/doi.org\/10.1007\/s00345-016-1875-6","journal-title":"World J Urol."},{"issue":"1","key":"5663_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/end.2006.20.33","volume":"20","author":"AR El-Nahas","year":"2006","unstructured":"El-Nahas AR, El-Assmy AM, Shoma AM et al (2006) Self-retaining ureteral stents: analysis of factors responsible for patients\u2019 discomfort. J Endourol. 20(1):33\u201337. https:\/\/doi.org\/10.1089\/end.2006.20.33","journal-title":"J Endourol."},{"key":"5663_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrurol.2014.340","volume":"12","author":"D Lange","year":"2014","unstructured":"Lange D, Bidnur S, Hoag N et al (2014) Ureteral stent-associated complications\u2014where we are and where we are going. Nat Rev Urol. 12:17\u201325. https:\/\/doi.org\/10.1038\/nrurol.2014.340","journal-title":"Nat Rev Urol."},{"issue":"4","key":"5663_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4103\/0970-1591.57910","volume":"25","author":"M Monga","year":"2009","unstructured":"Monga M, Miyaoka R (2009) Ureteral stent discomfort: Etiology and management. Ind J Urol 25(4):455\u2013460. https:\/\/doi.org\/10.4103\/0970-1591.57910","journal-title":"Ind J Urol"},{"key":"5663_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/iju.13311","volume":"24","author":"P Betschart","year":"2017","unstructured":"Betschart P, Zumstein V, Piller A et al (2017) Prevention and treatment of symptoms associated with indwelling ureteral stents: a systematic review. Int J Urol. 24:250\u2013259. https:\/\/doi.org\/10.1111\/iju.13311","journal-title":"Int J Urol."},{"issue":"05","key":"5663_CR18","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/bju.14416","volume":"122","author":"BS Tae","year":"2018","unstructured":"Tae BS, Cho S, Jeon BJ et al (2018) Does mirabegron relieve ureteric stent-related discomfort? a prospective, randomized, multicentre study. BJU Int. 122(05):866\u2013872. https:\/\/doi.org\/10.1111\/bju.14416","journal-title":"BJU Int."},{"issue":"1","key":"5663_CR19","first-page":"54","volume":"73","author":"A Sahin","year":"2020","unstructured":"Sahin A, Yildirim C, Yuksel OH et al (2020) Treatment of ureteral catheter related symptoms; mirabegron versus tamsulosin\/solifenacin combination: a randomized controlled trial. Arch Esp Urol. 73(1):54\u201359","journal-title":"Arch Esp Urol."},{"key":"5663_CR20","doi-asserted-by":"publisher","first-page":"18844","DOI":"10.1038\/s41598-022-23795-5","volume":"12","author":"Q-L Tang","year":"2022","unstructured":"Tang Q-L, Zhou S, Liu Y-Q et al (2022) Efficacy and safety of combination of mirabegron and solifenacin in patients with double-J stent related overactive bladder: a prospective study. Sci Rep 12:18844. https:\/\/doi.org\/10.1038\/s41598-022-23795-5","journal-title":"Sci Rep"},{"key":"5663_CR21","doi-asserted-by":"publisher","DOI":"10.1089\/08927790152596352","author":"A Rane","year":"2001","unstructured":"Rane A, Saleemi A, Cahill D et al (2001) Have stent-related symptoms anything to do with placement technique? J Endourol. https:\/\/doi.org\/10.1089\/08927790152596352","journal-title":"J Endourol"},{"key":"5663_CR22","doi-asserted-by":"publisher","DOI":"10.1089\/end.2006.0252","author":"BH Chew","year":"2007","unstructured":"Chew BH, Knudsen BE, Nott L et al (2007) Pilot study of ureteral movement in stented patients: first step in understanding dynamic ureteral anatomy to improve stent comfort. J Endourol. https:\/\/doi.org\/10.1089\/end.2006.0252","journal-title":"J Endourol."},{"issue":"4","key":"5663_CR23","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.urology.2011.10.056","volume":"79","author":"WM Sameh","year":"2012","unstructured":"Sameh WM, Eid AA (2012) Pressure transmission through ureteric stents: a novel in vivo human study. Urology. 79(4):766\u2013770. https:\/\/doi.org\/10.1016\/j.urology.2011.10.056","journal-title":"Urology."},{"issue":"4","key":"5663_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/s0090-4295(01)01644-2","volume":"59","author":"HB Joshi","year":"2002","unstructured":"Joshi HB, Okeke A, Newns N et al (2002) Characterization of urinary symptoms in patients with ureteral stents. Urology. 59(4):511\u2013516. https:\/\/doi.org\/10.1016\/s0090-4295(01)01644-2","journal-title":"Urology."},{"key":"5663_CR25","doi-asserted-by":"publisher","DOI":"10.1089\/089277901750134421","author":"HB Joshi","year":"2001","unstructured":"Joshi HB, Stainthorpe A, Keeley FX et al (2001) Indwelling ureteral stents: evaluation of quality of life to aid outcome analysis. J Endourol. https:\/\/doi.org\/10.1089\/089277901750134421","journal-title":"J Endourol"},{"key":"5663_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1985.tb07021.x","author":"JWA Ramsay","year":"1985","unstructured":"Ramsay JWA, Payne SR, Cosling PT et al (1985) The effects of double J stenting on unobstructed ureters. An experimental and clinical study. Br J Urol. https:\/\/doi.org\/10.1111\/j.1464-410x.1985.tb07021.x","journal-title":"Br J Urol"},{"issue":"04","key":"5663_CR27","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/s0022-5347(17)37976-4","volume":"146","author":"HA Mosli","year":"1991","unstructured":"Mosli HA, Farsi HM, Al-Zimaity MF et al (1991) Vesicoureteral reflux in patients with double pigtail stents. J Urol. 146(04):966\u2013969. https:\/\/doi.org\/10.1016\/s0022-5347(17)37976-4","journal-title":"J Urol."},{"key":"5663_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00931","author":"L Grundy","year":"2018","unstructured":"Grundy L, Caldwell A, Brierley SM (2018) Mechanisms underlying overactive bladder and interstitial cystitis\/painful bladder syndrome. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2018.00931","journal-title":"Front Neurosci."},{"issue":"02","key":"5663_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ejogrb.2013.08.002","volume":"170","author":"M Schoenfeld","year":"2013","unstructured":"Schoenfeld M, Fuermetz A, Muenster M et al (2013) Sexuality in German urogynecological patients and healthy controls: is there a difference with respect to the diagnosis? Eur J Obstet Gynecol Reprod Biol. 170(02):567\u2013570. https:\/\/doi.org\/10.1016\/j.ejogrb.2013.08.002","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"05","key":"5663_CR30","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1067\/mob.2003.273","volume":"188","author":"S-K Yip","year":"2003","unstructured":"Yip S-K, Chan A, Pang S et al (2003) The impact of urodynamic stress incontinence and detrusor overactivity on marital relationship and sexual function. Am J Obstet Gynecol. 188(05):1244\u20131248. https:\/\/doi.org\/10.1067\/mob.2003.273","journal-title":"Am J Obstet Gynecol."},{"issue":"09","key":"5663_CR31","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jsxm.2022.07.003","volume":"19","author":"ST Celenay","year":"2022","unstructured":"Celenay ST, Karaaslan Y, Ozdemir E (2022) Effects of pelvic floor muscle training on sexual dysfunction, sexual satisfaction of partners, urinary symptoms, and pelvic floor muscle strength in women with overactive bladder: a randomized controlled study. J Sex Med 19(09):1421\u20131430. https:\/\/doi.org\/10.1016\/j.jsxm.2022.07.003","journal-title":"J Sex Med"},{"key":"5663_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000025761","author":"X-D Lin","year":"2021","unstructured":"Lin X-D, Lin N, Ke Z-B et al (2021) Effects of overactive bladder syndrome on female sexual function. Medicine. https:\/\/doi.org\/10.1097\/md.0000000000025761","journal-title":"Medicine"},{"key":"5663_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejogrb.2021.08.026","volume":"265","author":"J Quaghebeur","year":"2021","unstructured":"Quaghebeur J, Petros P, Wyndaele J-J et al (2021) Pelvic-floor function, dysfunction, and treatment. Eur J Obstet Gynecol Reprod Biol. 265:143\u2013149. https:\/\/doi.org\/10.1016\/j.ejogrb.2021.08.026","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"5663_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ijir.2016.16","author":"A Alwaal","year":"2016","unstructured":"Alwaal A, Tian X, Huang Y et al (2016) Female sexual function following mid-urethral slings for the treatment of stress urinary incontinence. Int J Impot Res. https:\/\/doi.org\/10.1038\/ijir.2016.16","journal-title":"Int J Impot Res."},{"issue":"8","key":"5663_CR35","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2014.303","volume":"311","author":"L Mody","year":"2014","unstructured":"Mody L, Juthani-Mehta M (2014) Urinary tract infections in older women. JAMA. 311(8):844\u2013854. https:\/\/doi.org\/10.1001\/jama.2014.303","journal-title":"JAMA."},{"key":"5663_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00092","author":"KV Meriwether","year":"2019","unstructured":"Meriwether KV, Lei Z, Singh R et al (2019) The vaginal and urinary microbiomes in premenopausal women with interstitial cystitis\/bladder pain syndrome as compared to unaffected controls: a pilot cross-sectional study. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2019.00092","journal-title":"Front Cell Infect Microbiol."},{"issue":"5","key":"5663_CR37","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.eururo.2003.11.023","volume":"45","author":"A Salonia","year":"2004","unstructured":"Salonia A, Zanni G, Nappi RE et al (2004) Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Eur Urol. 45(5):642\u2013648. https:\/\/doi.org\/10.1016\/j.eururo.2003.11.023","journal-title":"Eur Urol."},{"key":"5663_CR38","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-5538.ibju.2016.0303","author":"A Zachariou","year":"2017","unstructured":"Zachariou A, Filiponi M (2017) The effect of extended release tolterodine used for overactive bladder treatment on female sexual function. Int Braz j Urol. https:\/\/doi.org\/10.1590\/s1677-5538.ibju.2016.0303","journal-title":"Int Braz j Urol."},{"key":"5663_CR39","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1007\/s00192-022-05173-x","volume":"33","author":"F Dal Farra","year":"2022","unstructured":"Dal Farra F, Aquino A, Tarantino AG et al (2022) Effectiveness of myofascial manual therapies in chronic pelvic pain syndrome: a systematic review and meta-analysis. Int Urogynecol J. 33:2963\u20132976. https:\/\/doi.org\/10.1007\/s00192-022-05173-x","journal-title":"Int Urogynecol J."},{"key":"5663_CR40","first-page":"491","volume":"7","author":"D Leibovici","year":"2005","unstructured":"Leibovici D, Cooper A, Lindner A et al (2005) Ureteral stents: morbidity and impact on quality of life. Isr Med Assoc J. 7:491\u2013494","journal-title":"Isr Med Assoc J."},{"issue":"12","key":"5663_CR41","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1111\/j.1743-6109.2008.00976.x","volume":"5","author":"S Hajebrahimi","year":"2008","unstructured":"Hajebrahimi S, Azaripour A, Sadeghi-Bazargani H (2008) Tolterodine immediate release improves sexual function in women with overactive bladder. J Sex Med 5(12):2880\u20132885. https:\/\/doi.org\/10.1111\/j.1743-6109.2008.00976.x","journal-title":"J Sex Med"},{"issue":"5","key":"5663_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0090-4295(01)01635-1","volume":"59","author":"O Yamaguchi","year":"2002","unstructured":"Yamaguchi O (2002) Beta3-adrenoceptors in human detrusor muscle. Urology. 59(5):25\u201329. https:\/\/doi.org\/10.1016\/s0090-4295(01)01635-1","journal-title":"Urology."},{"issue":"4","key":"5663_CR43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.23736\/s2724-6051.23.05225-4","volume":"75","author":"A Cicione","year":"2023","unstructured":"Cicione A, Nacchia A, Baldassarri V et al (2023) Adverse events related to alpha-blockers: analysis of real-life data from Eudra-Vigilance. Minerva Urol Nephrol. 75(4):479\u201385. https:\/\/doi.org\/10.23736\/s2724-6051.23.05225-4","journal-title":"Minerva Urol Nephrol."},{"issue":"6","key":"5663_CR44","doi-asserted-by":"publisher","DOI":"10.1177\/1756287217702797","volume":"9","author":"A Tubaro","year":"2017","unstructured":"Tubaro A, Batista JE, Nitti VW et al (2017) Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies. Ther Adv Urol. 9(6):137154. https:\/\/doi.org\/10.1177\/1756287217702797","journal-title":"Ther Adv Urol."},{"issue":"3","key":"5663_CR45","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.eururo.2018.03.020","volume":"74","author":"C Kelleher","year":"2018","unstructured":"Kelleher C, Hakimi Z, Zur R et al (2018) Efficacy and tolerability of mirabegron compared with antimuscarinic monotherapy or combination therapies for overactive bladder: a systematic review and network meta-analysis. Eur Urol. 74(3):324\u2013333. https:\/\/doi.org\/10.1016\/j.eururo.2018.03.020","journal-title":"Eur Urol."},{"issue":"8","key":"5663_CR46","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40265-018-0924-4","volume":"78","author":"ED Deeks","year":"2018","unstructured":"Deeks ED (2018) Mirabegron: a review in overactive bladder syndrome. Drugs. 78(8):833\u2013844. https:\/\/doi.org\/10.1007\/s40265-018-0924-4","journal-title":"Drugs."},{"key":"5663_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12894-018-0377-9","volume":"18","author":"A Zachariou","year":"2018","unstructured":"Zachariou A, Mamoulakis C, Filiponi M et al (2018) The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study. BMC Urol. 18:1\u20138. https:\/\/doi.org\/10.1186\/s12894-018-0377-9","journal-title":"BMC Urol."},{"issue":"5","key":"5663_CR48","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jpain.2008.12.001","volume":"10","author":"RB Fillingim","year":"2009","unstructured":"Fillingim RB, King CD, Ribeiro-Dasilva MC et al (2009) Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 10(5):447\u2013485. https:\/\/doi.org\/10.1016\/j.jpain.2008.12.001","journal-title":"J Pain"},{"issue":"4","key":"5663_CR49","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4103\/0970-1591.57910","volume":"25","author":"R Miyaoka","year":"2009","unstructured":"Miyaoka R, Monga M (2009) Ureteral stent discomfort: Etiology and management. Indian J Urol. 25(4):455\u2013460. https:\/\/doi.org\/10.4103\/0970-1591.57910","journal-title":"Indian J Urol."},{"issue":"12","key":"5663_CR50","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1517\/13543784.8.12.2073","volume":"8","author":"Carlos Forray","year":"2001","unstructured":"Forray Carlos, Noble Stewart A (2001) Subtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia. Expert Opin Investig Drugs. 8(12):2073\u20132096. https:\/\/doi.org\/10.1517\/13543784.8.12.2073","journal-title":"Expert Opin Investig Drugs."},{"issue":"1","key":"5663_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/2090598x.2019.1690824","volume":"18","author":"K Deliveliotis","year":"2019","unstructured":"Deliveliotis K, Papatsoris AG, Skolarikos A et al (2019) Management of stent-related symptoms with the use of \u03b1-blockers: a meta-analysis. Arab J Urol 18(1):14\u201321. https:\/\/doi.org\/10.1080\/2090598x.2019.1690824","journal-title":"Arab J Urol"},{"issue":"2","key":"5663_CR52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4103\/0253-7613.178825","volume":"48","author":"R Manjunatha","year":"2016","unstructured":"Manjunatha R, Pundarikaksha HP, Madhusudhana HR et al (2016) A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia. Indian J Pharmacol. 48(2):134\u2013140. https:\/\/doi.org\/10.4103\/0253-7613.178825","journal-title":"Indian J Pharmacol."}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05663-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05663-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05663-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:52:56Z","timestamp":1767966776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05663-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5663"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05663-9","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The studies involving human participants were reviewed and approved the Medical Ethics Committee of the \u00a0Anning First People's Hospital Affiliated to Kunming University of Science and Technology (Ethics Approval No. 2022-96 (scientific research)-01). Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"299"}}